Une coloscopie à 50 ans pour tout le monde?

Registre morphologique des tumeurs année 2000. Ministère de la Santé Grand-Duché de Luxembourg. FERLA Y J., BRAY F., PISANI P. — Globocan 2000: Cancer incidence, mortality and prevalence worldwide. IARCPress, Lyon, http:www-dep.iarc.r/globocan/globocan.html BLEIBERG H., KEMENY N., ROUGIER Ph. — Colorectal cancer: a clinical guide to therapy. Martin Dunitz, 2002. WEBER J., SCHEIDEN R. — Le cancer colorectal au Luxembourg et les groupes à risque. 8e Journée Luxembourgeoise de Gastroentérologie, 1998. Statistiques des causes de décès. Ministère de la Santé Grand-Duché de Luxembourg, 1998. VOGELSTEIN B., FEARON E.R., HAMILTON S.R. — Genetic alterations during colorectal-tumor development.N. Engl. J. Med., 1988,319, 525–532. VOGELSTEIN B., KINZLER K.W. — The multistep nature of cancer.TIG, 1993,9, 138–141. STRYKER S.J., WOLFF B.G., CULP CE.et al. — Natural history of colon polyps.Gastroenterology, 1987,93, 1009–1013. HART A.R., KUDO S., MACKAY E.H.et al. — Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes.Gut, 1998,43, 229–231. FUCHS C.H.S., EDWARD L., GIOVANNUCCI M.D.et al. — A prospective study of family history and the risk of colorectal cancer.Engl. J. Med., 1994,331, 1669–1674. CRIPPS N.P.J., HEALD R.J. — Family based colorectal cancer screening in a district hospital.Gut, 1996,38, 421–425. HOULSTON R.S., MURDAY V., HARACOPAS C.et al. — Screening and genetic consulting for relatives of patients with colorectal cancer in a family cancer clinic.Br. Med. J., 1990,301, 366–368. ST JOHN D.J., MCDERMOTT F.T., HOPPER J.L.et al. — Cancer risk in relatives of patients with common colorectal cancer.Ann. Intern. Med., 1993,118, 785–790. GUILLEM J.G., FORDE K. A., TREAT M.R.et al. — Colono- scopic screening for the neoplasms in asymptomatic firstdegree relatives of colon cancer patients.Dis. Colon Rectum, 1992,35, 523–529. PARIENTE A., MILAN CH., LAFON J.et al. — Colonoscopic screening in first degree relatives of patients with sporadic colorectal cancer.Gastroenterology, 1998,115, 7–12. SAUAR J., HAUSKEN T., HOFF G.et al. — Colonoscopic screening examination of relatives of patients with colorectal cancer.Scan. J. Gastroenterol., 1992,27, 6612. WINAWER S.W., ZAUBER A.G., GERDES H.et al. — Risk of colorectal cancer in the families of patients with adenomatous polyps.N. Engl. J. Med., 1996,334, 82–87. MACDONALD F., MORTON D.G., RINDL P.M.et al. — Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based study.Br. Med. J., 1992,304, 869–872. LYNCH H.T., SMYRK T. — Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review.Cancer, 1996,78, 1149–1167. VASEN H.F.A., MECKLIN J.P., MEERAKHAN P.et al. — The international collaborative group on hereditary nonpolyposis colorectal cancer.Dis. Colon Rectum, 1991,34, 424–425. PORSCHEN R., STROHMEYER G. — Dysplasie und Karzinomrisiko bei Colitis ulcerosa.Dtsch Med. Wschr., 1991,116, 1682–1688. BRENTNALL T.A., HAGGIT R.C., RABINOVITCH P.S. — Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.Gastroenterology, 1996,110, 331–338. MANDEL J.S., BOND J.H., CHURCH T.R.et al. — Reducing mortality from colorectal cancer by screening for fecal occult blood.N. Engl. J. Med., 1993,328, 1365–1371 (erratumN. Engl. J. Med., 1993,329, 672). KRONBERG O., FENGER C., OLSEN J.et al. — Randomised study of screening for colorectal cancer with faecaloccult-blood test.Lancet, 1996,348, 1467–1471. HARDCASTLE J.D., CHAMBERLAIN J.O., ROBINSON M.H.et al. — Randomised controlled trial of feacal-occult-blood screening for colorectal cancer.Lancet, 1996,348, 1472–1477. PORSCHEN R., STROHMEYER G. — Prophylaxe des kolorektalen Karzinoms durch endoskopischeUntersuchungen.Z. Gastroenterol., 1992,30, 823–828. WINAWER S.J., ZAUBER A.G., HO M.N.et al. — Prevention of colorectal cancer by colonoscopic polypectomy.N. Engl. J. Med., 1993,329, 1977–1981. THIS-EVENSEN E., HOFF G.S., SAUAR J.et al. — Population bases surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I.Scand. J. Gastroenterol., 1999,34, 414–420. ATKIN W.S., COOK C.F., CUZICK J.et al. — Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicenter randomized trial.Lancet, 2002,359, 1291–1300. SELBY J.V., FRIEDMAN G.D., QUESENBERRY C.P.et al. — A case control study of screening sigmoidoscopy and mortality from colorectal cancer.N. Engl. J. Med., 1992,326, 653–657. MÜLLER A.D., SONNENBERG A. — Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case control study of 32702 veterans.Ann. Intern. Med., 1995,123, 1741–1748. MÜLLER A.D., SONNENBERG A. — Protection by endoscopy against death from colorectal cancer.Arch. Intern. Med., 1995,155, 1741–1748. HOFF G., SAUAR M.H., VATN S.et al. — Polypectomy of adenomas in the Prevention of Colorectal Cancer: 10 years’ follow up of the Telemark Polyp Study I.Scand. J. Gastroenterol., 1996,31, 1006–1010. KAVANAGH A.M., GIOVANNUCCI E.L., FUCHS C.S.et al. — Screening endoscopy and risk of colorectal cancer in United States men.Cancer Causes Control, 1998,9, 455–462. GREENE L.F. — Distribution of colorectal neoplasms.Am. Surg., 1983,46, 62–65. PAINTER J., SAUNDERS D.B., BELL G.D.et al. — Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design.Endoscopy, 1999,31, 227–231. KADAKIA S.C., WROBLESWKI C.S., KADAKIA A.S.et al. — Prevalence of proximal colonic polyps in average-risk asymptomatic patients with negative fecal occult blood tests and flexible sigmoidoscopy.Gastrointest. Endosc., 1996,44, 112–117. LIEBERMANN D.A., SMITH F.W. — Screening for colon malignancy with colonoscopy.Am. J. Gastroenterol., 1991,86, 946–951. NICHOLSON F.B., KORMAN M.G., STERN A.I.et al. — Distribution of colorectal adenomas: implications for bowel cancer screening.Med. J. Aust., 2000,172, 428–430. LIEBERMAN D., WEISS D., BOND J.H.et al. — Use of colonoscopy to screen asymptomatic adults for colorectal cancer.N. Engl. J. Med., 2000,343, 162–168. IMPERIALE T.F., WAGNER D.R., LIN C.H.Y. — Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.N. Engl. J. Med., 2000,343, 169–174. LEVIN T.R., PALITZ A., GROSSMANN S.et al. — Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.JAMA, 1999,281, 1611–1617. DINNING J.P., HIXSON L.J., CLARK L.C. — Prevalence of distal colonie neoplasia associated with proximal colon cancers.Arch. Intern. Med., 1994,154, 853–856. REX D.K., CHAK A., VASUDEVA R.et al. — Prospective determination of distal colon findings in average-risk patients with proximal colon cancer.Gastrointest. Endosc., 1999,49, 727–730. BERRY D.P., CLARKE P., HARDCASTEL J.D. — Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.Br. J. Surg., 1997,84, 1274–1276. RASMUSSEN N., KRONBORG O., FENGLER C.et al. — Possible advantages and drawbacks of adding flexible sigmoidoscopy to Hemoccult-II in screening for colorectal cancer.Scan. J. Gastroenterol., 1999,34, 73–78. WINAWER S.J., FLEHINGER B.J., SCHOTTENFELD D.et al. — Screening for colorectal cancer with fecal occult blood testing and sigmoidsocopy.J. Natl Cancer Inst., 1993,85, 1311–1318. LIEBERMANN D.A., WEISS D.G. — One-time screening for colorectal cancer with combined fecal occult blood testing and examination of the distal colo.N. Engl. J. Med., 2001,345, 555–560. IMPERIALE T.F., WAGNER D.R., LIN C.Y.et al. — Results of screening colonoscopy among persons 40 to 49 years of age.N. Engl. J. Med., 2002,346, 1781–1785. US Preventive Services Task Force — Screening for colorectal cancer: recommendation and rationale.Ann. Intern. Med., 2002,137, 129–141. HIXSON L.J., FEMERTY M.B., SAMPLINER R.E.et al — Prospective study of the frequency and size distribution of polyps missed by colonoscopy.J. Nati Cancer Inst., 1990,82, 1769–1772. REX D.K., CUTLER C.S., LEMMEL G.T.et al. — Colonoscopy miss rate of adenomas determined by back-to-back colonoscopies.Gastroenterology, 1997,112, 24–28. ALDRIDGE A.J., SIMSON J.N. — Histological assessment of colorectal adenomas by size. Are polyps less than 10 mm in size clinically important ?Eur. J. Surg., 2001,167, 777–781. HOFSTAD B., VATN M.H., ANDERSEN S.N.et al. — Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years.Gut, 1996,39, 449–456. REX D.K., CUMMINGS O.W., HELPER D.J.et al. — 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons.Gastroenterology, 1996,111, 1178–1181. ZAUBER A.G., WINAWER S.J., BOND J.D.et al. — Long term National Polyp Study (NPS) data on post-polypectomy surveillance.Endoscopy, 1999,31 Suppl.1, E13, Abstract 39.06. HOFF G., SAUR J., HOFSTAD B.et al. — The National guidelines for surveillance after polypectomy: 10 years intervals.Scand. J. Gastroenterol., 1996,31, 834–836. LANGENBACH M.R., SCHMIDT J., NEUMANN J.et al. — Therapieverzögerung bei Kolon- und Rektumkarzinom: Ein multifaktorielles Geschehen.Z. Gastroenterol., 2003,41, 823, Abstract 227. JOHNSON C.D., AHLQUIST D.A. — Computed tomography colonography (virtual colonoscopy): a new method for colorectal screening.Gut, 1999,44, 301–305.